MCM
RGEN icon

Moore Capital Management’s Repligen RGEN Stock Holding History

Moore Capital Management’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,000
Closed -$1.07M – 797
2025
Q3 		$1.07M Buy
+8,000
New +$972K 0.01% 409

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Moore Capital Management's RGEN Position: Q2 2026 in Review

Moore Capital Management opened a new position in Repligen (RGEN) in Q2 2026: 37,549 shares worth $5.12M. The stake represents 0.08% of the portfolio and ranks #220 among its holdings. This is a return to the name: Moore Capital Management previously reported a position in RGEN as recently as Q4 2025.

Moore Capital Management first reported a position in RGEN in Q3 2023 and has held it in 6 quarters since. The position peaked at $24.6M in Q4 2025. 481 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Moore Capital Management held 37,549 shares of Repligen worth $5.12M as of Q2 2026.
  • Repligen was a new Moore Capital Management position in Q2 2026.
  • Repligen made up 0.08% of Moore Capital Management's portfolio in Q2 2026, its #220 holding.
  • Moore Capital Management first reported a position in Repligen in Q3 2023 and has held it in 6 quarters since.
  • Moore Capital Management's Repligen position peaked at $24.6M in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Moore Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.